Extendicare Normal Course Issuer Bid Approved by TSX

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Extendicare Normal Course Issuer Bid Approved by TSX

MARKHAM, ON --(Marketwired - December 30, 2015) - Extendicare Inc. ("Extendicare" or the "Company") ( TSX : EXE ) today announced that it has received the approval of the Toronto Stock Exchange (the "TSX") to renew its normal course issuer bid (the "Bid") for up to 8,610,000 of its common shares (the "Common Shares") through the facilities of the TSX, and on alternative Canadian trading systems.

As at December 24, 2015, there were 87,953,291 Common Shares issued and outstanding. The Company's Bid for up to 8,610,000 represents approximately 10% of the public float on December 24, 2015, calculated in accordance with the rules of the TSX.

Purchases under the Bid may commence on January 5, 2016 and will terminate on January 4, 2017, or on such earlier date as the Bid is complete. The actual number of Common Shares purchased under the Bid and the timing of any such purchases will be at the Company's discretion. Purchases of Common Shares will be made through the facilities of the TSX, and on alternative Canadian trading systems, in accordance with the TSX rules. Subject to the TSX's block purchase exception, on any trading day, purchases under the Bid will not exceed 59,253 Common Shares. The price that Extendicare will pay for any Common Shares purchased under the Bid will be the prevailing market price at the time of purchase and any Common Shares purchased by the Company will be cancelled.

The Company's board of directors has authorized the Bid because it believes that it is an appropriate use of the Company's available funds to purchase Common Shares when the market price of the Common Shares does not fully reflect their underlying value. Any Common Shares purchased under the Bid will increase the proportionate interest of, and may be advantageous to, all remaining shareholders. The Company has purchased for cancellation an aggregate of 1,111,789 Common Shares at a weighted average price of $7.20 per share under its previous outstanding normal course issuer bid that expired today.

ABOUT EXTENDICARE

Extendicare is a leading provider of care and services for seniors throughout Canada. Through our network of 116 operated senior care centres (62 owned/54 managed), as well as our home health care operations, we are committed to delivering care throughout the health care continuum to meet the needs of a growing seniors' population in Canada. Our qualified and highly trained workforce of 22,800 individuals is dedicated to helping people live better through a commitment to quality service and a passion for what we do.

Forward-looking Statements

Information provided by Extendicare from time to time, including this release, contains or may contain forward-looking statements concerning anticipated financial events, results, circumstances, economic performance or expectations with respect to Extendicare and its subsidiaries, including, without limitation, statements regarding its business operations, business strategy, and financial condition. Forward-looking statements can be identified because they generally contain the words "expect", "intend", "anticipate", "believe", "estimate", "project", "plan" or "objective" or other similar expressions or the negative thereof. Forward-looking statements reflect management's beliefs and assumptions and are based on information currently available, and Extendicare assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Extendicare to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on Extendicare's forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at www.sedar.com and on Extendicare's website at www.extendicare.com .

For further information, contact: Elaine E. Everson Vice President and Chief Financial Officer Phone: (905) 470-4000 Fax: (905) 470-4003 Email: eeverson@extendicare.com Visit Extendicare's Website at www.extendicare.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Transactions by Management at Danske Bank A/S Unveiled

Updated Category News Views 115

Recent Management Changes at Danske Bank A/S In finance, transparency holds great importance, especially for organizations like Danske Bank A/S. This announcement outlines important transactions carried out by key individuals who are required to disclose such activities under the EU Market Abuse Regulation. These reports help ensure that all stakeholders stay informed,...

Continue Reading
Urgently’s Innovative Technology Earns Prestigious Award

Updated Category News Views 188

Urgently’s Recognition in Automotive Technology Urgently, Inc. (NASDAQ: ULY), a prominent U.S.-based provider specializing in digital roadside and mobility assistance solutions, has achieved significant acclaim by winning the ‘Overall Transportation Tech of the Year’ award at the esteemed AutoTech Breakthrough Awards. This event acknowledges outstanding innovations...

Continue Reading
Innovative Therapeutics: Surrozen's Upcoming Investor Engagements

Updated Category News Views 95

Exciting Investor Opportunities Ahead for Surrozen Surrozen, Inc. (Nasdaq: SRZN), a trailblazer in biotechnology, is gearing up to engage with investors at significant healthcare conferences in the near future. The company specializes in pioneering targeted therapeutics that modulate the Wnt pathway, focusing primarily on addressing severe eye diseases. With a reputation...

Continue Reading
Insightful Journey into Alliance Pharma's Recent Trading Moves

Updated Category News Views 173

Understanding the Recent Public Disclosure from Alliance Pharma plc Alliance Pharma plc has recently made a significant public disclosure under the guidelines set by the Takeover Code, particularly the vital Rule 8.5. This disclosure is a crucial aspect of maintaining transparency within the market, especially for companies like Alliance Pharma, where stakeholder...

Continue Reading
Investor Insights: Understanding agilon health, Inc.'s Current Situation

Updated Category News Views 231

Navigating Turbulent Waters for agilon health, Inc. The investment landscape can be unpredictable, particularly when companies like agilon health, Inc. face leadership changes. Recent events have prompted Pomerantz LLP to investigate potential claims on behalf of agilon investors, bringing attention to significant issues surrounding the company's operations. Understanding...

Continue Reading